Total Payments
$5,087
2024 Payments
$175.68
Companies
35
Transactions
272
Payment Breakdown by Category
Food & Beverage$5,074 (99.7%)
Education$12.99 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,074 | 270 | 99.7% |
| Education | $12.99 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $953.39 | 29 | $0 (2023) |
| Novo Nordisk Inc | $605.75 | 33 | $0 (2024) |
| Lilly USA, LLC | $511.94 | 26 | $0 (2024) |
| ABBVIE INC. | $270.85 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $265.66 | 13 | $0 (2024) |
| PFIZER INC. | $263.97 | 14 | $0 (2022) |
| Astellas Pharma US Inc | $198.77 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $171.05 | 12 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $169.18 | 12 | $0 (2019) |
| GlaxoSmithKline, LLC. | $166.04 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.68 | 9 | ABBVIE INC. ($99.62) |
| 2023 | $780.80 | 32 | AstraZeneca Pharmaceuticals LP ($214.98) |
| 2022 | $785.69 | 29 | Lilly USA, LLC ($166.65) |
| 2021 | $602.32 | 37 | Novo Nordisk Inc ($128.55) |
| 2020 | $782.80 | 32 | AstraZeneca Pharmaceuticals LP ($234.25) |
| 2019 | $360.53 | 19 | AstraZeneca Pharmaceuticals LP ($139.13) |
| 2018 | $600.00 | 42 | Novo Nordisk Inc ($154.46) |
| 2017 | $998.75 | 72 | Novartis Pharmaceuticals Corporation ($133.96) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/29/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/14/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/14/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Central Nervous System | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardio-renal | ||||||
| 01/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardio-renal | ||||||
| 11/17/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Endocrinology | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardio-renal | ||||||
| 10/24/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Biological | ||||||
| 10/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardio-renal | ||||||
| 06/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Biological | ||||||
| 05/25/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Cardio-renal | ||||||
| 05/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
About Dr. Daniel Richter, MD
Dr. Daniel Richter, MD is a Family Medicine healthcare provider based in Missouri Valley, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730246745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Richter, MD has received a total of $5,087 in payments from pharmaceutical and medical device companies, with $175.68 received in 2024. These payments were reported across 272 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,074).
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Missouri Valley, IA
- Active Since 01/02/2007
- Last Updated 09/15/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730246745
Products in Payments
- FARXIGA (Drug) $562.17
- BREZTRI (Drug) $272.81
- Kerendia (Drug) $265.66
- MOUNJARO (Drug) $204.28
- TRULICITY (Drug) $189.72
- ENTRESTO (Drug) $169.18
- ELIQUIS (Drug) $150.57
- Myrbetriq (Drug) $141.22
- HMG-CoA reductase inhibitor. (Drug) $134.76
- Ozempic (Drug) $131.05
- JARDIANCE (Drug) $104.01
- XARELTO (Drug) $98.37
- SOLIQUA (Drug) $93.62
- LINZESS (Drug) $86.16
- CHANTIX (Drug) $82.09
- RYBELSUS (Drug) $79.06
- Victoza (Drug) $78.87
- TEFLARO (Drug) $77.25
- JANUVIA (Drug) $73.16
- UBRELVY (Drug) $69.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Missouri Valley
Dr. David Minnick, Md, MD
Family Medicine — Payments: $3,903
Family Medicine $3,903
Dr. Allison Pagan, Md, MD
Family Medicine — Payments: $1,039
Family Medicine $1,039
Robert Cunard, M.d, M.D
Family Medicine — Payments: $806.43
Family Medicine $806.43
Dr. Rory Keys, Md, MD
Family Medicine — Payments: $747.75
Family Medicine $747.75